diazoxide has been researched along with Congenital Disorders of Glycosylation in 1 studies
Diazoxide: A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group.
diazoxide : A benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies.
Congenital Disorders of Glycosylation: A genetically heterogeneous group of heritable disorders resulting from defects in protein N-glycosylation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hyperinsulinism was permanent in two of these three cases." | 1.72 | Hyperinsulinism May Be Underreported in Hypoglycemic Patients with Phosphomannomutase 2 Deficiency ( Alikaşifoğlu, A; Dursun, A; Gönç, N; Ozon, A; Sivri, HS; Tokatlı, A; Vurallı, D; Yıldız, Y, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vurallı, D | 1 |
| Yıldız, Y | 1 |
| Ozon, A | 1 |
| Dursun, A | 1 |
| Gönç, N | 1 |
| Tokatlı, A | 1 |
| Sivri, HS | 1 |
| Alikaşifoğlu, A | 1 |
1 other study available for diazoxide and Congenital Disorders of Glycosylation
| Article | Year |
|---|---|
Hyperinsulinism May Be Underreported in Hypoglycemic Patients with Phosphomannomutase 2 Deficiency
Topics: Congenital Disorders of Glycosylation; Diazoxide; Humans; Hyperinsulinism; Hypoglycemia; Hypoglycemi | 2022 |